DRDO's anti-Covid drug 2-DG will reduce recovery time, oxygen dependency, says Union health minister
You Might Like
💡 newsR Knowledge: Other News Mentions
WHO accepts Bharat Biotech's Expression of Interest for Covaxin emergency use listingThe World Health Organisation (WHO) has accepted Bharat Biotech’s expression of interest (EoI) for the emergency use listing (EUL) of India's first..
Portugal's COVID recovery plan is first to receive Brussels' approval
Credit: euronews (in English) Duration: 02:14Published
This is the BEST Indian city to live in during COVID-19, says studyThis Indian city offers the best medical infrastructure, open area and low population density, crucial livability parameters during COVID-19.
PM Modi says focus must be on repairing and preparing the health infrastructure| Oneindia News
Credit: Oneindia Duration: 02:36Published
2-DG drug initially developed for cancer treatment, lures coronavirus by looking like glucose: Former DRDO scientist
DRDO invites EoI to transfer technology of 2-DG drug for bulk productionThe Defence Research and Development Organisation (DRDO), which developed 2-Deoxy-D- Glucose (2-DG), a drug used for treatment of Covid-19 patients, has called..
Contrary to vow, DRDO drug has steep price tag of Rs 990 a sachetContrary to promises that the indigenously developed Covid-19 drug 2-deoxy-D-glucose (2-DG) would be priced affordably to ensure it reaches as many patients as..
DRDO's new Covid-19 drug 2-DG: All you need to know, how effective is it? | Oneindia News
Credit: Oneindia Duration: 01:24Published
Related videos from verified sources
Related news from verified sources